Skip to main content

Table 2 Baseline Vaccine-Eligibility, Initiation, and Completion of Recommended Vaccinations Among Adult Refugees in a Connecticut district, 2013–2015

From: Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013–2015

  Baseline Immunity Among All 111 Subjects at the Time of Resettlement
n (%)
Vaccinations One Year after Resettlement Among Vaccine-Eligible Subjects
n (%)
Vaccine Immune Non-immune (Vaccine-Eligible) Initiated Completed
Aggregatea 27 (24%) 84 (76%) 78 (93%) 42 (50%)
MMR (2 doses) 83 (75%) 28 (25%) 26 (93%) 20 (71%)
Hep A (2 doses) 93 (84%) 18 (16%) 16 (89%) 15 (83%)
Hep B (3 doses) 33 (30%) 78 (70%) 72 (92%) 46 (59%)
Tdap (1 dose) N/A 111 (100%) 106 (96%) 106 (96%)
HPV (3 doses)b N/A 34 (31%) 5 (15%) 1 (20%)
Varicella 100 (90%) 11 (10%) N/A N/A
  1. Note: MMR Measles, mumps, rubella, Hep A Hepatitis A, Hep B Hepatitis B, Tdap Tentanus, diphtheria, acellular pertussis, HPV Human papillomavirus. Baseline immunity determined by laboratory testing for immunoglobulin G or documentation of completed overseas vaccination
  2. a Aggregate of measles, mumps, rubella, hepatitis A/B; we considered subjects to be vaccine-eligible if they required any of these vaccines
  3. b HPV vaccine eligibility was assumed for all subjects < 26 years-old. No subject had documentation of prior HPV vaccination